ChenGuang Biotech Group Co., Ltd. (300138.SZ)
CNY 8.97
(-0.44%)
CNY 8.97
(-0.44%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 3.11 Billion CNY | 83.99% |
| 2022 | 1.69 Billion CNY | -1.1% |
| 2021 | 1.71 Billion CNY | -3.01% |
| 2020 | 1.76 Billion CNY | 7.04% |
| 2019 | 1.64 Billion CNY | 50.57% |
| 2018 | 1.09 Billion CNY | 41.72% |
| 2017 | 772.99 Million CNY | 100.81% |
| 2016 | 384.93 Million CNY | 5141.59% |
| 2015 | 7.34 Million CNY | -96.32% |
| 2014 | 199.67 Million CNY | -49.7% |
| 2013 | 396.95 Million CNY | 62.68% |
| 2012 | 244 Million CNY | 399.23% |
| 2011 | -81.54 Million CNY | 63.9% |
| 2010 | -225.88 Million CNY | -297.35% |
| 2009 | 114.46 Million CNY | 85.53% |
| 2008 | 61.69 Million CNY | 82.25% |
| 2007 | 33.85 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 2.79 Billion CNY | -10.28% |
| 2024 Q2 | 1.93 Billion CNY | -30.8% |
| 2024 Q3 | 957.93 Million CNY | -50.3% |
| 2023 Q2 | 1.12 Billion CNY | -38.79% |
| 2023 Q1 | 1.83 Billion CNY | 8.28% |
| 2023 Q3 | 1 Billion CNY | -10.66% |
| 2023 Q4 | 3.11 Billion CNY | 210.73% |
| 2023 FY | 3.11 Billion CNY | 83.99% |
| 2022 FY | 1.69 Billion CNY | -1.1% |
| 2022 Q2 | 1.25 Billion CNY | -32.31% |
| 2022 Q3 | 539.67 Million CNY | -56.93% |
| 2022 Q4 | 1.69 Billion CNY | 213.82% |
| 2022 Q1 | 1.85 Billion CNY | 8.11% |
| 2021 Q3 | 543.97 Million CNY | -40.56% |
| 2021 FY | 1.71 Billion CNY | -3.01% |
| 2021 Q2 | 915.14 Million CNY | -13.71% |
| 2021 Q1 | 1.06 Billion CNY | -39.93% |
| 2021 Q4 | 1.71 Billion CNY | 214.81% |
| 2020 Q2 | 1.12 Billion CNY | -32.13% |
| 2020 Q3 | 724.56 Million CNY | -35.58% |
| 2020 FY | 1.76 Billion CNY | 7.04% |
| 2020 Q4 | 1.76 Billion CNY | 143.69% |
| 2020 Q1 | 1.65 Billion CNY | 0.47% |
| 2019 Q2 | 778.14 Million CNY | -25.68% |
| 2019 FY | 1.64 Billion CNY | 50.57% |
| 2019 Q3 | 714.82 Million CNY | -8.14% |
| 2019 Q4 | 1.64 Billion CNY | 130.75% |
| 2019 Q1 | 1.04 Billion CNY | -4.42% |
| 2018 Q3 | 636.11 Million CNY | -14.63% |
| 2018 Q1 | 765.38 Million CNY | -0.98% |
| 2018 FY | 1.09 Billion CNY | 41.72% |
| 2018 Q4 | 1.09 Billion CNY | 72.21% |
| 2018 Q2 | 745.13 Million CNY | -2.65% |
| 2017 Q3 | 125.22 Million CNY | -64.88% |
| 2017 Q4 | 772.99 Million CNY | 517.26% |
| 2017 FY | 772.99 Million CNY | 100.81% |
| 2017 Q1 | 333.84 Million CNY | -13.27% |
| 2017 Q2 | 356.59 Million CNY | 6.81% |
| 2016 Q4 | 384.93 Million CNY | 288.42% |
| 2016 Q3 | -204.29 Million CNY | -1152.98% |
| 2016 Q2 | -16.3 Million CNY | 79.39% |
| 2016 FY | 384.93 Million CNY | 5141.59% |
| 2016 Q1 | -79.09 Million CNY | -1176.97% |
| 2015 Q1 | 202.73 Million CNY | 1.53% |
| 2015 Q3 | 102.89 Million CNY | -35.8% |
| 2015 FY | 7.34 Million CNY | -96.32% |
| 2015 Q4 | 7.34 Million CNY | -92.86% |
| 2015 Q2 | 160.27 Million CNY | -20.95% |
| 2014 Q2 | 290.56 Million CNY | -18.49% |
| 2014 Q4 | 199.67 Million CNY | 107.11% |
| 2014 Q3 | 96.4 Million CNY | -66.82% |
| 2014 Q1 | 356.47 Million CNY | -10.2% |
| 2014 FY | 199.67 Million CNY | -49.7% |
| 2013 Q2 | 316.09 Million CNY | 14.01% |
| 2013 FY | 396.95 Million CNY | 62.68% |
| 2013 Q4 | 396.95 Million CNY | 46.35% |
| 2013 Q3 | 271.23 Million CNY | -14.19% |
| 2013 Q1 | 277.25 Million CNY | 13.63% |
| 2012 Q3 | 156.62 Million CNY | 35.4% |
| 2012 Q4 | 244 Million CNY | 55.79% |
| 2012 Q1 | 801.89 Thousand CNY | 100.98% |
| 2012 FY | 244 Million CNY | 399.23% |
| 2012 Q2 | 115.67 Million CNY | 14325.0% |
| 2011 Q1 | -168 Million CNY | 25.62% |
| 2011 Q2 | -183.26 Million CNY | -9.08% |
| 2011 Q4 | -81.54 Million CNY | 67.98% |
| 2011 FY | -81.54 Million CNY | 63.9% |
| 2011 Q3 | -254.7 Million CNY | -38.98% |
| 2010 Q3 | 138.5 Million CNY | 6.03% |
| 2010 Q4 | -225.88 Million CNY | -263.08% |
| 2010 FY | -225.88 Million CNY | -297.35% |
| 2010 Q2 | 130.63 Million CNY | 0.0% |
| 2009 Q4 | 114.46 Million CNY | 0.0% |
| 2009 FY | 114.46 Million CNY | 85.53% |
| 2008 FY | 61.69 Million CNY | 82.25% |
| 2007 FY | 33.85 Million CNY | 0.0% |